Anonymous ID: 7b63f3 Sept. 25, 2018, 1:22 p.m. No.3182487   🗄️.is 🔗kun

https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621503.htm

On Sept. 24, 2018, the Food and Drug Administration granted regular approval to duvelisib (COPIKTRA, Verastem, Inc.) for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies.